Advanced Tumor Profiling for Personalized Targeted Anti-cancer Treatments


Deep tumor profiling to identify molecular features including gene variants and gene expression to identify patients who may benefit from targeted anti-cancer treatments.

For Whom

Patients who have been advised molecular tumor profiling for selection of targeted anti-cancer treatments.


Tumor components including proteins, DNA and RNA are isolated from tumor tissue and blood and used for molecular profiling to identify features associated with response to targeted anti-cancer agents.


CellDx’s deep tumor profiling provides a detailed insight into tumor molecular dynamics which can inform selection of safe and more efficacious treatment regimens.

Revolutionary Technology

CellDx is validated stringently to meet global standards.


  • Includes assessment of all molecular biomarkers indicated in the NCCN guidelines.

  • Evaluates additional clinically relevant biomarkers.

  • Guides treatment selection in labeled as well as label-agnostic settings.


A Simple Blood Test To Detect Cancer Early,
So That It Could Be Cured.

A Simple Blood Test for Cancer Diagnosis.
It Could Save Your Life.

We can help physicians make more informed treatment decisions.

A Powerful Test For Better Management and
Monitoring of Cancer Treatments.


Contact Us


India     |    Worldwide

(Messages Only)

4 Frederick Sanger Road, The Surrey Research Park, Guildford, Surrey, GU2 7YD,
United Kingdom
95488 Eckersdorf,
F8, D Road, Ambad, Nashik,
Maharashtra – 422010.